Skip to content
Screener

Constellium CSTM Depreciation, Amortization And Impairment Charge

Depreciation, Amortization And Impairment Charge at other companies

The J.M. Smucker Company logo
The J.M. Smucker CompanySJM
$134.4M-87.8%
The J.M. Smucker Company logo
The J.M. Smucker CompanySJM
$10.1M+9.8%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$13.27M-21.3%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$13.27M-21.3%
PRA Group logo
PRA GroupPRAA
$2.61M-3.3%
Tesla, Inc. logo
Tesla, Inc.TSLA
$1.62B+13.0%

Segments

By segment

See full
P&ARP$48M+6.7%
A&T$19M+5.6%
AS&I$15M-11.8%
H&C$1M-50.0%

Other financials

Income statement

See full
Revenue$2.7B+30.7%
Gross profit$480.0M+82.5%
Net income$146.0M+306%
EPS (diluted)$1.04+316%

Balance sheet

See full
Cash & equivalents$163.0M+22.6%
Total debt$2.0B-10.8%
Total equity$1.2B+59.7%
Total assets$6.1B+13.1%

Cash flow

See full
Operating cash flow$161.0M+41.2%
CapEx$77.0M0.0%
Free cash flow$84.0M+127%

Valuation

See full
Market cap$3.88B+107%
Enterprise value$5.71B+43.7%
P/E7.1×
P/S0.4×+0.2×

Profitability

See full
Gross margin16.3%+4.0pp
Net margin5.7%
FCF margin2.3%+1.7pp

Returns & leverage

See full
Return on equity53.8%
Debt / equity1.6×-1.3×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by Constellium in its filing.

Tagged under the XBRL concept cstm:DepreciationAmortizationAndImpairmentCharge.

The source filing: Constellium’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 12:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001563411-26-000192
(in millions of U.S. dollars)Three months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
A&T(19)(18)(37)(35)
P&ARP(48)(45)(95)(89)
AS&I(15)(17)(35)(33)
H&C (A)(1)(2)(3)(3)
Total depreciation, amortization and impairment expense(83)(82)(170)(160)

Item 1. Financial Statements

FAQ

What is Constellium's depreciation, amortization and impairment charge?
Constellium (CSTM) reported depreciation, amortization and impairment charge of $83M in Q2 2026.
How has Constellium's depreciation, amortization and impairment charge changed year-over-year?
Constellium's depreciation, amortization and impairment charge increased by 1.2% year-over-year, from $82M to $83M.
What is the long-term trend for Constellium's depreciation, amortization and impairment charge?
Over 3 years (2022 to 2025), Constellium's depreciation, amortization and impairment charge has grown at a 4.7% compound annual growth rate (CAGR), from $306M to $351M.
What does depreciation, amortization and impairment charge mean?
The total non-cash expense recognized during the period related to the systematic allocation of the cost of tangible and intangible assets over their useful lives, combined with any write-downs of asset carrying values. This metric reflects the consumption of capital investments and potential loss in asset value, impacting reported operating profitability.

Ask your AI about Constellium's depreciation, amortization and impairment charge.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude